Terms of Service
The rules for using Caeloryx, N.O.V.A., the Portal, and related testing services.
1. Agreement
By using a Caeloryx service, you agree to these terms and any platform rules that also apply, including Discord's terms. If you do not agree, do not use the service.
2. Development software
N.O.V.A. V1.2 “Sentinel” and the Portal are under active development. Features may change, fail, be removed, or become temporarily unavailable. Testing access is provided without a guarantee of uptime or continued availability.
3. Responsible use
You must follow the Acceptable Use Policy and Community Guidelines. You may not use Caeloryx to break the law, harm others, bypass safeguards, disrupt services, impersonate people, or gain unauthorized access.
4. AI limitations
AI output may be incomplete, outdated, or incorrect. You are responsible for reviewing output before relying on it, especially for medical, legal, financial, safety-critical, or other high-impact decisions.
5. Your content
You remain responsible for content you submit. You grant Caeloryx the limited permission needed to process that content to provide, secure, and improve the service. Do not submit content you do not have the right to use.
6. Caeloryx materials
The Caeloryx name, branding, Portal design, documentation, and original software are protected by applicable intellectual-property law. These terms do not transfer ownership to users.
7. Suspension and termination
Access may be limited or removed for abuse, security risk, legal requirements, repeated rule violations, or actions that threaten users or the service.
8. Disclaimers and liability
Services are provided on an “as available” basis to the extent permitted by law. Caeloryx does not promise that output will be accurate or that services will be uninterrupted. Nothing here excludes rights or liability that cannot legally be excluded.
9. Contact
Questions may be sent to caeloryx.contact@gmail.com.
These materials are provided as a practical draft for an independent project and are not legal advice. Caeloryx should obtain qualified legal review before a broad commercial launch.